Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2014: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2012: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Outline of Final Research Achievements |
The neonatal herpes with encephalitis, which was resistance to acyclovir (ACV) therapy, was virologically confirmed to be caused by ACV-resistant herpes simplex virus type 1 (HSV-1) in this study for the first time. DNA polymerase-associated ACV-resistant HSV-1 was generated by selection of the HSV-1 with S2242. Most of the viruses were sensitive or hypersensitive to ganciclovir, while they were cross-resistant to foscarnet. In recent years, the number of patients with immunodeficiency including those who received organ transplantation, suggesting that drug-resistant HSV-1 infections might become a great concern. The diagnostic system including the sensitivity assay and effective therapeutic strategies should be prepared in advance.
|